| Primary |
| Fungal Infection |
33.3% |
| Candidiasis |
13.3% |
| Dry Mouth |
13.3% |
| Rash |
13.3% |
| Cardiac Valve Prosthesis User |
6.7% |
| Oesophagitis |
6.7% |
| Oral Fungal Infection |
6.7% |
| Tension Headache |
6.7% |
|
| Drug Ineffective |
18.8% |
| International Normalised Ratio Increased |
18.8% |
| Gastrointestinal Disorder |
12.5% |
| Abdominal Pain Upper |
6.3% |
| Abortion Induced |
6.3% |
| Angioedema |
6.3% |
| Drug Eruption |
6.3% |
| Gastric Ulcer |
6.3% |
| Incorrect Route Of Drug Administration |
6.3% |
| Oesophagitis |
6.3% |
| Urticaria |
6.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.8% |
| Product Used For Unknown Indication |
14.5% |
| Renal Transplant |
11.8% |
| Restlessness |
8.2% |
| Tuberculosis |
7.3% |
| Oral Fungal Infection |
4.5% |
| Anxiety |
3.6% |
| Candidiasis |
3.6% |
| Fungal Infection |
3.6% |
| Dementia Alzheimer's Type |
2.7% |
| Depression |
2.7% |
| Aphthous Stomatitis |
1.8% |
| Atrial Fibrillation |
1.8% |
| Bronchopneumonia |
1.8% |
| Candida Infection |
1.8% |
| Diabetes Mellitus Non-insulin-dependent |
1.8% |
| Dry Mouth |
1.8% |
| Insomnia |
1.8% |
| Pruritus |
1.8% |
| Agitation |
0.9% |
|
| International Normalised Ratio Increased |
8.7% |
| Rash Maculo-papular |
8.7% |
| Stevens-johnson Syndrome |
8.7% |
| Abdominal Wall Haematoma |
4.3% |
| Drug Ineffective |
4.3% |
| Fibrin Increased |
4.3% |
| Haemolytic Anaemia |
4.3% |
| Haemorrhage |
4.3% |
| Hepatitis |
4.3% |
| Hypertransaminasaemia |
4.3% |
| Hypoproteinaemia |
4.3% |
| Mouth Ulceration |
4.3% |
| Necrosis |
4.3% |
| Oesophagitis |
4.3% |
| Oral Fungal Infection |
4.3% |
| Pruritus |
4.3% |
| Pyrexia |
4.3% |
| Renal Impairment |
4.3% |
| Retinal Degeneration |
4.3% |
| Retinal Neovascularisation |
4.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.3% |
| Product Used For Unknown Indication |
21.2% |
| Diffuse Large B-cell Lymphoma |
12.8% |
| Prophylaxis |
4.6% |
| Pain |
3.8% |
| Constipation |
3.1% |
| Hypertension |
2.9% |
| Breast Cancer |
2.1% |
| Multiple Myeloma |
2.0% |
| Osteoporosis |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Infection Prophylaxis |
1.5% |
| Liver Transplant |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Acute Myeloid Leukaemia |
1.4% |
| Rash |
1.3% |
| Gastric Cancer |
1.2% |
| Prostate Cancer |
1.1% |
| Renal Transplant |
1.1% |
| Nausea |
1.0% |
|
| Weight Decreased |
10.9% |
| Vomiting |
10.3% |
| Febrile Neutropenia |
6.6% |
| Thrombocytopenia |
6.6% |
| White Blood Cell Count Decreased |
6.6% |
| Wound Infection Staphylococcal |
6.6% |
| Renal Failure |
5.9% |
| Neutropenia |
5.6% |
| Pneumonia |
5.0% |
| Respiratory Failure |
4.1% |
| Vision Blurred |
3.8% |
| Death |
3.4% |
| Pulmonary Embolism |
3.4% |
| Rectal Ulcer |
3.4% |
| Renal Failure Acute |
3.4% |
| Pyrexia |
3.1% |
| B-cell Lymphoma |
2.8% |
| Hyperglycaemia |
2.8% |
| Septic Shock |
2.8% |
| Visual Impairment |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Urinary Tract Infection |
33.3% |
|
| Prothrombin Time Shortened |
100.0% |
|
